| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1041610215000848 |
| P698 | PubMed publication ID | 26061118 |
| P50 | author | Jason Karlawish | Q67175778 |
| P2093 | author name string | Rebecca A Johnson | |
| P2860 | cites work | Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease | Q24595802 |
| How are we going to live with Alzheimer's disease? | Q27025608 | ||
| Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria | Q30458193 | ||
| Practice parameter: risk of driving and Alzheimer's disease (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology | Q30883903 | ||
| Seeking assent and respecting dissent in dementia research | Q33611135 | ||
| The A4 study: stopping AD before symptoms begin? | Q33725775 | ||
| What makes clinical research ethical? | Q33924008 | ||
| Research involving cognitively impaired adults. | Q51949502 | ||
| Alzheimer's disease patients' and caregivers' capacity, competency, and reasons to enroll in an early-phase Alzheimer's disease clinical trial. | Q51951791 | ||
| Utility and limits of the mini mental state examination in evaluating consent capacity in Alzheimer's disease. | Q51952937 | ||
| Core safeguards for clinical research with adults who are unable to consent. | Q51963320 | ||
| Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. | Q51967278 | ||
| Prevalence and impact of caregiving: a detailed comparison between dementia and nondementia caregivers. | Q51985122 | ||
| Competency to consent to research: a psychiatric overview. | Q52098060 | ||
| Do Alzheimer's disease patients want to participate in a treatment decision, and would their caregivers let them? | Q53269984 | ||
| American Academy of Neurology position statement on physician reporting of medical conditions that may affect driving competence. | Q54540065 | ||
| Advance directives in dementia research: The opinions and arguments of clinical researchers − an empirical study | Q57913905 | ||
| Ethical dilemmas: should antipsychotics ever be prescribed for people with dementia? | Q58667999 | ||
| Driving in patients with dementia | Q67971292 | ||
| The effects of an enhanced environment on nursing home residents who pace | Q74512426 | ||
| Views of potential subjects toward proposed regulations for clinical research with adults unable to consent | Q77851730 | ||
| Do clinicians follow a risk-sensitive model of capacity-determination? An experimental video survey | Q79917110 | ||
| Driving and dementia: a review of the literature | Q80980321 | ||
| Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges. | Q33960193 | ||
| When does an illness begin: genetic discrimination and disease manifestation | Q34081019 | ||
| Genetic testing for Alzheimer's and long-term care insurance | Q34097151 | ||
| Psychiatric and physical morbidity effects of dementia caregiving: prevalence, correlates, and causes | Q34371058 | ||
| The full spectrum of ethical issues in dementia care: systematic qualitative review | Q34754635 | ||
| The brain, the science and the media. The legal, corporate, social and security implications of neuroimaging and the impact of media coverage | Q35084523 | ||
| Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk | Q35208130 | ||
| Preservation of the capacity to appoint a proxy decision maker: implications for dementia research | Q35952203 | ||
| The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment | Q36121618 | ||
| The ethics of informed consent in Alzheimer disease research | Q36330685 | ||
| Risk disclosure and preclinical Alzheimer's disease clinical trial enrollment | Q36609607 | ||
| Preclinical Alzheimer disease-the challenges ahead | Q36813484 | ||
| Older adults' attitudes toward enrollment of non-competent subjects participating in Alzheimer's research | Q37082761 | ||
| Person-centred care of people with severe Alzheimer's disease: current status and ways forward | Q37109667 | ||
| Surrogate consent for dementia research: a national survey of older Americans | Q37145557 | ||
| Using AD biomarker research results for clinical care: a survey of ADNI investigators | Q37227059 | ||
| Disclosure of APOE genotype for risk of Alzheimer's disease | Q37423417 | ||
| Interpreting the clinical significance of capacity scores for informed consent in Alzheimer disease clinical trials | Q37606812 | ||
| A conceptual framework and ethics analysis for prevention trials of Alzheimer Disease. | Q38076634 | ||
| Hormone treatment of children and adolescents with gender dysphoria: an ethical analysis | Q38251259 | ||
| Palliative care and quality of life for people with dementia: medical and psychosocial interventions | Q38312342 | ||
| Improving medical decisions for incapacitated persons: does focusing on "accurate predictions" lead to an inaccurate picture? | Q39247640 | ||
| Older persons' opinions about life-sustaining procedures in the face of dementia | Q39518603 | ||
| The economic burden of Alzheimer's disease care | Q41095758 | ||
| Confidentiality in preclinical Alzheimer disease studies: when research and medical records meet | Q42006679 | ||
| Driving cessation and increased depressive symptoms | Q46215140 | ||
| How proxies make decisions about research for patients with Alzheimer's disease | Q47574555 | ||
| Advance directives, dementia, and withholding food and water by mouth | Q48076689 | ||
| Use of a patient preference predictor to help make medical decisions for incapacitated patients | Q48085800 | ||
| Identifying the barriers and challenges to voting by residents in nursing homes and assisted living settings | Q48591756 | ||
| Respecting the margins of agency: Alzheimer's patients and the capacity to value | Q48737782 | ||
| A changing landscape for advance directives in dementia research | Q48949324 | ||
| Driving and Alzheimer's disease: the risk of crashes. | Q50605428 | ||
| Alzheimer's disease care: costs and potential savings. | Q50637587 | ||
| Patient preference predictors, apt categorization, and respect for autonomy. | Q50659815 | ||
| Lay perceptions regarding the competence of persons with Alzheimer's disease. | Q50933055 | ||
| Desktop Medicine | Q51639140 | ||
| The capacity to vote of persons with Alzheimer's disease. | Q51924520 | ||
| Addressing the ethical, legal, and social issues raised by voting by persons with dementia. | Q51937472 | ||
| P433 | issue | 10 | |
| P921 | main subject | research ethics | Q1132684 |
| P304 | page(s) | 1635-1647 | |
| P577 | publication date | 2015-06-10 | |
| P1433 | published in | International Psychogeriatrics | Q15761572 |
| P1476 | title | A review of ethical issues in dementia | |
| P478 | volume | 27 |
| Q54988819 | Cognitive Assessment of Patients With Alzheimer's Disease by Telemedicine: Pilot Study. |
| Q64097161 | Ethical Issues in the Treatment of Late-Stage Alzheimer’s Disease |
| Q39269360 | Informed Consent to Research with Cognitively Impaired Adults: Transdisciplinary Challenges and Opportunities. |
| Q50119513 | Social health and dementia: a European consensus on the operationalization of the concept and directions for research and practice |
| Q39051115 | The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial |
| Q52150029 | The practice and ethics of dementia care. |
Search more.